Karyopharm Therapeutics (KPTI) PT Lowered to $22 at Barclays

February 12, 2021 8:26 AM EST
Get Alerts KPTI Hot Sheet
Price: $6.20 +1.81%

Rating Summary:
    11 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 8 | New: 46
Trade Now! 
Join SI Premium – FREE
Barclays analyst Peter Lawson lowered the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $22.00 (from $26.00) while maintaining a Overweight rating.

You May Also Be Interested In

Related Categories

Analyst PT Change